课题基金 / 基金详情

Community-engaged implementation strategies for acceptance interventions to improve access to care for people with HIV and injection drug use

Community-engaged implementation strategies for acceptance interventions to improve access to care for people with HIV and injection drug use
社区参与的接受干预实施战略,以改善艾滋病毒感染者和注射吸毒者获得护理的机会
批准号:
10762655
负责人:
Karsten Lunze
金额:
$8.9万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-01 至 2025-08-31

项目摘要

项目成果

Karsten Lunze的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY Various barriers including stigma can limit access to HIV and substance use for people with HIV who inject drugs. Acceptance and Commitment Treatment (ACT) empowers these people to cope with stigma and other care barriers, leading to an increase in health services utilization. ACT is an evidence-based intervention that uses acceptance, mindfulness, and behavior change processes to improve psychological flexibility. In the SCRIPT randomized controlled trial, we showed that ACT could increase antiretroviral therapy (ART) initiation and substance use care engagement for people with HIV and active injection drug use. This study recruited participants at a community-based harm reduction site and trained psychologists delivered the intervention at a community clinic, but community-engaged implementation strategies have not yet been studied. Implementation strategies for evidence-based care access interventions for people with HIV and injection drug use are rare. This project will narrow this gap, assessing appropriate implementation outcomes and their relations with trial outcomes. We will also explore implementation strategies, to be tested in future hybrid effectiveness-implementation trials of ACT. Using the existing mixed-methods data from the SCRIPT trial, this R03 proposes to assess implementation outcomes and identify implementation strategies (including intervention adaptation, training, fidelity monitoring). The results from this project will aid in access to health services for the stigmatized population of people with HIV who inject drugs and provide the groundwork for future trials testing acceptance-based approaches to improve care access for people with HIV, substance use and potentially other stigmatized conditions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Gabapentin to Reduce Alcohol and Improve Viral Load Suppression - Promoting "Treatment as Prevention"
  • 批准号:
    10706554
  • 项目类别:
  • 资助金额:
    $64.81万
  • 财政年份:
    2022
  • 负责人:
    Karsten Lunze
  • 依托单位:
Gabapentin to Reduce Alcohol and Improve Viral Load Suppression - Promoting "Treatment as Prevention"
  • 批准号:
    10541347
  • 项目类别:
  • 资助金额:
    $73.85万
  • 财政年份:
    2022
  • 负责人:
    Karsten Lunze
  • 依托单位:
Stigma, Risk Behaviors and Health Care among HIV-infected Russian People Who Inject Drugs
  • 批准号:
    10199478
  • 项目类别:
  • 资助金额:
    $16.04万
  • 财政年份:
    2018
  • 负责人:
    Karsten Lunze
  • 依托单位:
Stigma, Risk Behaviors and Health Care among HIV-infected Russian People Who Inject Drugs
  • 批准号:
    9767759
  • 项目类别:
  • 资助金额:
    $24.78万
  • 财政年份:
    2018
  • 负责人:
    Karsten Lunze
  • 依托单位:
海外基金